A phase Ib safety and tolerability study of a pan class I PI3K inhibitor buparlisib (BKM120) and gefitinib (gef) in EGFR TKI-resistant NSCLC von Tan, Daniel Shao-Weng, Lim, Kiat Hon, Tai, Wai Meng, Ahmad, Aziah, Pan, Summer, Ng, Quan Sing, Ang, Mei-Kim, Gogna, Apoorva, Ng, Yuen Li, Tan, Bien Soo, Lee, Haur Yueh, Krisna, Sakktee Sai, Lau, Dawn PX, Zhong, Liz, Iyer, Gopal, Chowbay, Balram, Lim, Alvin ST, Takano, Angela, Lim, Wan-Teck, Tan, Eng-Huat

Volltext

Risk Factors Associated with Arterial Stiffness in Diabetic Nephropathy in an Asian Population Cohort von Lim Su Chi, Phua E Joo, Sharon F Nne, Amizah B Asrap, Wong DS Melvin, Tan SH Clara, Liu J Jun, Toy W Ching, Ng X Wei, Lau PX Dawn, Pek LT Sharon, Woon Kaing, Lin LF Bernice, S Tavintharan, Sum C Fang

Volltext